Ziwig Biotech

Ziwig Biotech is a French startup aiming to revolutionize women's health by utilizing a holistic approach and developing products, services, and a care ecosystem rooted in science and tailored to each individual's unique biology. The company collaborates closely with medical experts and engineers, leveraging advanced technologies such as artificial intelligence and Next Generation human RNA Sequencing. The incorporation of disruptive technologies into a patient-centered ecosystem supports the advent of precision medicine, offering individualized, predictive, and participatory care for women's well-being and quality of life. Notably, Ziwig's efforts have led to publications in esteemed international peer-reviewed scientific journals such as diagnostics, Nature Scientific Reports, and Journal of Clinical Medicine. Established in 2020 and headquartered in France, Ziwig Biotech recently secured Angel Round investment in December 2022, with Sebastien Breteau as the investor. The company operates primarily in the Health Care, Health and Wellness, and Women's Health sectors, signaling its commitment to addressing crucial areas within the healthcare industry. Join Ziwig's journey towards advancing women's health by following them on Instagram at @ziwigfrance.